EPAS1 and paraganglioma: Moreover, in the present study, we have noted that the patients with phaeochromocytoma/paraganglioma having EPAS1 mutations had no mutations in phaeochromocytoma/paraganglioma-susceptible gene panels except NF1 in two patients with Neurofibromatosis 1.